PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients

被引:28
作者
Alyasiri, Nisreen Sherif [1 ]
Mehdi, Syed Jafar [1 ]
Alam, M. Shabbir [1 ]
Ali, Asgar [1 ]
Mandal, Ashish K. [2 ]
Gupta, Sunita [3 ]
Singh, Ishwar [4 ]
Rizvi, M. Moshahid Alam [1 ]
机构
[1] Jamia Millia Islamia, Dept Biosci, Genome Biol Lab, New Delhi 110025, India
[2] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India
[3] Maulana Azad Inst Dent Sci, New Delhi, India
[4] Maulana Azad Med Coll, Dept Otolaryngol Head & Neck Surg, New Delhi, India
关键词
Apoptosis; Immunohistochemistry; Oral cancer; PTEN; Phospho-Akt; TUMOR-SUPPRESSOR GENE; CLINICOPATHOLOGICAL SIGNIFICANCE; PREDICTIVE FACTORS; CANCER; EXPRESSION; PHOSPHORYLATION; PTEN/MMAC1; BREAST; HEAD; NECK;
D O I
10.1007/s00432-011-1077-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose The tumor suppressor gene PTEN negatively regulates Akt, a downstream mediator phosphoinositol 3-kinase. Several studies have reported the role of PTEN gene in Akt downregulation and apoptosis induction in different cancers and cell lines. However, the role of loss of PTEN expression in Akt activation and spontaneous apoptosis in oral squamous cell carcinoma clinical specimens is not well established. Methods We investigated the expression of PTEN and phospho-Akt in 146 formalin-fixed (archived) paraffin-embedded oral squamous cell carcinoma tissue sections through immunohistochemical analysis. Programmed cell death (apoptosis) was determined by Terminal deoxynucleotidyl Transferase Biotin-dUTP Nick End Labeling assay. Results Sixty-one percent loss of PTEN expression and 68.5% Akt activation was observed in oral squamous cell carcinoma. A significant correlation was found between loss of PTEN expression and Akt activation. Loss of PTEN expression and Akt activation were further correlated with different clinical parameters and found to be significantly correlated with tumor stage. Apoptotic index was estimated and correlated with PTEN expression and Akt activation. The percentage of apoptotic cells varied from 0.2 to 14.1%. Low apoptotic index was observed in 105 (72%) of samples, and it was found to be significantly related with loss of PTEN expression and phospho-Akt Conclusion The present study confirms the contribution of loss of PTEN expression in Akt phosphorylation and spontaneous apoptosis suppression in the specimens of oral cancer. Both PTEN and phospho-Akt are likely to be concerned with oral cancer progression and reduced incidence of spontaneous apoptosis
引用
收藏
页码:103 / 109
页数:7
相关论文
共 39 条
[1]
Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity [J].
Ali, IU ;
Schriml, LM ;
Dean, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (22) :1922-1932
[2]
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth [J].
Altomare, DA ;
Wang, HQ ;
Skele, KL ;
De Rienzo, A ;
Klein-Szanto, AJ ;
Godwin, AK ;
Testa, JR .
ONCOGENE, 2004, 23 (34) :5853-5857
[3]
Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01 [J].
Amornphimoltham, P ;
Sriuranpong, V ;
Patel, V ;
Benavides, F ;
Conti, CJ ;
Sauk, J ;
Sausville, EA ;
Molinolo, AA ;
Gutkind, JS .
CLINICAL CANCER RESEARCH, 2004, 10 (12) :4029-4037
[4]
[Anonymous], 2001, CALCULATION CHI SQUA
[5]
Prognostic and predictive factors in oral cancer:: the role of the invasive tumour front [J].
Bànkfalvi, A ;
Piffkò, J .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2000, 29 (07) :291-298
[6]
Prognostic and predictive factors in oral squamous cell cancer:: important tools for planning individual therapy? [J].
Bettendorf, O ;
Piffkò, J ;
Bànkfalvi, A .
ORAL ONCOLOGY, 2004, 40 (02) :110-119
[7]
Bowen KA, 2009, ANTICANCER RES, V29, P4439
[8]
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer [J].
Cappuzzo, F ;
Magrini, E ;
Ceresoli, GL ;
Bartolini, S ;
Rossi, E ;
Ludovini, V ;
Gregorc, V ;
Ligorio, C ;
Cancellieri, A ;
Damiani, S ;
Spreafico, A ;
Paties, CT ;
Lombardo, L ;
Calandri, C ;
Bellezza, G ;
Tonato, M ;
Crinò, L .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15) :1133-1141
[9]
Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma [J].
Chen, Q ;
Samaranayake, LP ;
Zhou, H ;
Xiao, L .
ORAL ONCOLOGY, 2000, 36 (01) :95-99
[10]
PTEN mutations in gliomas and glioneuronal tumors [J].
Duerr, EM ;
Rollbrocker, B ;
Hayashi, Y ;
Peters, N ;
Meyer-Puttlitz, B ;
Louis, DN ;
Schramm, J ;
Wiestler, OD ;
Parsons, R ;
Eng, C ;
von Deimling, A .
ONCOGENE, 1998, 16 (17) :2259-2264